ResearcherChiba UniversityNo recent work listed
Kosuke Sasaki
Matched on ORCID iD 0000-0003-4645-9063; OpenAlex author ID A5070148096. Sources: OpenAlex.
Their work
- Papers
- 3
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 12
2021: 3 papers
Papers 3
- Complement factor B regulates cellular senescence and is associated with poor prognosis in pancreatic cancer. Co-author DOI 10.1007/s13402-021-00614-z↗
- C4b-binding protein α-chain enhances antitumor immunity by facilitating the accumulation of tumor-infiltrating lymphocytes in the tumor microenvironment in pan… Co-author DOI 10.1186/s13046-021-02019-0↗
- Fucosylated C4b-binding protein α-chain, a novel serum biomarker that predicts lymph node metastasis in pancreatic ductal adenocarcinoma. Co-author DOI 10.3892/ol.2020.12388↗
Closest collaborators
The 12 strongest of 12 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Yoji Miyahara · 3 shared papers, 2021 · strength 0.37
- Paper C4b-binding protein α-chain enhances antitumor immunity by facilitating the accumulation of tumor-infiltrating lymphocy… DOI 10.1186/s13046-021-02019-0↗
- Paper Fucosylated C4b-binding protein α-chain, a novel serum biomarker that predicts lymph node metastasis in pancreatic duct… DOI 10.3892/ol.2020.12388↗
- Paper Complement factor B regulates cellular senescence and is associated with poor prognosis in pancreatic cancer. DOI 10.1007/s13402-021-00614-z↗
- Shigetsugu Takano · 3 shared papers, 2021 · strength 0.37
- Paper C4b-binding protein α-chain enhances antitumor immunity by facilitating the accumulation of tumor-infiltrating lymphocy… DOI 10.1186/s13046-021-02019-0↗
- Paper Fucosylated C4b-binding protein α-chain, a novel serum biomarker that predicts lymph node metastasis in pancreatic duct… DOI 10.3892/ol.2020.12388↗
- Paper Complement factor B regulates cellular senescence and is associated with poor prognosis in pancreatic cancer. DOI 10.1007/s13402-021-00614-z↗
- Katsunori Furukawa · 3 shared papers, 2021 · strength 0.37
- Paper C4b-binding protein α-chain enhances antitumor immunity by facilitating the accumulation of tumor-infiltrating lymphocy… DOI 10.1186/s13046-021-02019-0↗
- Paper Fucosylated C4b-binding protein α-chain, a novel serum biomarker that predicts lymph node metastasis in pancreatic duct… DOI 10.3892/ol.2020.12388↗
- Paper Complement factor B regulates cellular senescence and is associated with poor prognosis in pancreatic cancer. DOI 10.1007/s13402-021-00614-z↗
- Masayuki Ohtsuka · 3 shared papers, 2021 · strength 0.37
- Paper C4b-binding protein α-chain enhances antitumor immunity by facilitating the accumulation of tumor-infiltrating lymphocy… DOI 10.1186/s13046-021-02019-0↗
- Paper Fucosylated C4b-binding protein α-chain, a novel serum biomarker that predicts lymph node metastasis in pancreatic duct… DOI 10.3892/ol.2020.12388↗
- Paper Complement factor B regulates cellular senescence and is associated with poor prognosis in pancreatic cancer. DOI 10.1007/s13402-021-00614-z↗
- Kazuyuki Sogawa · 2 shared papers, 2021 · strength 0.23
- Paper Fucosylated C4b-binding protein α-chain, a novel serum biomarker that predicts lymph node metastasis in pancreatic duct… DOI 10.3892/ol.2020.12388↗
- Paper Complement factor B regulates cellular senescence and is associated with poor prognosis in pancreatic cancer. DOI 10.1007/s13402-021-00614-z↗
- Fumio Nomura · 2 shared papers, 2021 · strength 0.23
- Paper Fucosylated C4b-binding protein α-chain, a novel serum biomarker that predicts lymph node metastasis in pancreatic duct… DOI 10.3892/ol.2020.12388↗
- Paper Complement factor B regulates cellular senescence and is associated with poor prognosis in pancreatic cancer. DOI 10.1007/s13402-021-00614-z↗
- Satoshi Tomizawa · 1 shared paper, 2021 · strength 0.13
- Reiri Shimazaki · 1 shared paper, 2021 · strength 0.11
- Shingo Kagawa · 1 shared paper, 2021 · strength 0.11
- Masaru Miyazaki · 1 shared paper, 2021 · strength 0.11
- Mamoru Satoh · 1 shared paper, 2021 · strength 0.11
- Hideyuki Yoshitomi · 1 shared paper, 2021 · strength 0.11
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.